NDC 0078-0467

Desferal

Deferoxamine Mesylate

Desferal is a Intramuscular; Intravenous; Subcutaneous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Deferoxamine Mesylate.

Product ID0078-0467_0b1268f8-8b4b-4d4e-bdb4-d86d0279c889
NDC0078-0467
Product TypeHuman Prescription Drug
Proprietary NameDesferal
Generic NameDeferoxamine Mesylate
Dosage FormInjection, Powder, Lyophilized, For Solution
Route of AdministrationINTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS
Marketing Start Date1968-04-02
Marketing CategoryNDA / NDA
Application NumberNDA016267
Labeler NameNovartis Pharmaceuticals Corporation
Substance NameDEFEROXAMINE MESYLATE
Active Ingredient Strength500 mg/1
Pharm ClassesIron Chelating Activity [MoA],Iron Chelator [EPC]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 0078-0467-91

4 VIAL in 1 CARTON (0078-0467-91) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (0078-0467-61)
Marketing Start Date1968-04-02
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0078-0467-91 [00078046791]

Desferal INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA016267
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date1968-04-02

NDC 0078-0467-61 [00078046761]

Desferal INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Marketing CategoryNDA
Application NumberNDA016267
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2012-09-07

Drug Details

Active Ingredients

IngredientStrength
DEFEROXAMINE MESYLATE500 mg/1

OpenFDA Data

SPL SET ID:a7174843-5965-49fc-b842-f7eff7b48bbc
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1731352
  • 1731350

    • Pharmacological Class

    • Iron Chelating Activity [MoA]
    • Iron Chelator [EPC]

    NDC Crossover Matching brand name "Desferal" or generic name "Deferoxamine Mesylate"

    NDCBrand NameGeneric Name
    0078-0467Desferaldeferoxamine mesylate
    63323-597DeferoxamineDEFEROXAMINE MESYLATE
    63323-599DeferoxamineDEFEROXAMINE MESYLATE
    0409-2336Deferoxamine MesylateDeferoxamine Mesylate
    0409-2337Deferoxamine MesylateDeferoxamine Mesylate
    47781-623Deferoxamine mesylateDeferoxamine mesylate
    47781-624Deferoxamine mesylateDeferoxamine mesylate
    52609-4504Deferoxamine mesylateDeferoxamine mesylate
    52609-4505Deferoxamine mesylateDeferoxamine mesylate
    60505-6236Deferoxamine mesylateDeferoxamine mesylate
    60505-6237Deferoxamine mesylateDeferoxamine mesylate
    60505-6238Deferoxamine mesylateDeferoxamine mesylate
    68083-172Deferoxamine mesylateDeferoxamine mesylate
    68083-173Deferoxamine mesylateDeferoxamine mesylate

    Trademark Results [Desferal]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    DESFERAL
    DESFERAL
    72130271 0737030 Live/Registered
    Ciba Limited
    1961-10-19
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.